India is second largest market for pharma, biotech workforce: Report

Image
IANS New Delhi
Last Updated : Oct 10 2017 | 4:22 PM IST

With 13.7 per cent contribution to the global pharmaceuticals and biotechnology workforce, India has emerged as the second largest market for the industry, a report by professional networking giant LinkedIn has revealed.

The report, detailed in the newly released e-book "The Indian Pharma and Biotech Industry", showed that while New Delhi, Kolkata and Chandigarh are thriving grounds for talent in this sector in India, talent migration is highest to the US.

Nearly 48 per cent of the talent from the pharma and biotech industry in the US is moving to India and 36 per cent is migrating to the US from India, the company said in a statement on Tuesday.

Talent migrating to other countries mainly comprise of researchers, scientists, quality assurance professionals, statistics programmers and data analysts.

Talent coming to India include professionals hailing from sales followed by quality assurance and research.

The pharma and biotech professionals studied in this report were selected based on LinkedIn's 500+ million-member data as of September 2017.

LinkedIn analysed key platform engagement metrics and indices over the last year to map talent availability, migration, mobility and behaviour trends.

Major Indian and global pharma companies were analysed to understand engagement patterns of the talent pool.

--IANS

rt/amit/dg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 10 2017 | 4:12 PM IST

Next Story